3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
469
Neoplasms
327
Colorectal Neoplasms
236
Carcinoma, Non-Small-Cell Lung
233
Lung Neoplasms
200
Prostatic Neoplasms
179
Carcinoma, Hepatocellular
173
Stomach Neoplasms
138
Pancreatic Neoplasms
126
Leukemia, Myeloid, Acute
114
Uterine Cervical Neoplasms
110
Rectal Neoplasms
105
Multiple Myeloma
93
Recurrence
88
Squamous Cell Carcinoma of Head and Neck
84
Head and Neck Neoplasms
78
Neoplasm Metastasis
76
Ovarian Neoplasms
75
Brain Neoplasms
69
Colonic Neoplasms
68
Glioblastoma
66
Esophageal Neoplasms
66
Triple Negative Breast Neoplasms
65
Endometrial Neoplasms
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
56
Small Cell Lung Carcinoma
54
Disease
54
Motor Activity
53
Hematologic Neoplasms
53
Glioma
46
Interventions
pembrolizumab
1
enfortumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER
×
Advanced Bladder Cancer
×
Clear all
NCT07346053
2026-01-16
Chrono-EVP
British Columbia Cancer Agency
Phase 3
Not yet recruiting
224 enrolled
NCT07204496
2025-10-02
γδ-T-BLADDER
Shanghai 10th People's Hospital
Not yet recruiting
20 enrolled